Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 192

The DOI matches its Crossref record.

ICAM-1 as a molecular target for triple negative breast cancer

Open access
Guo, Peng, Huang, Jing, Wang, Liya, Jia, Di, Yang, Jiang, Dillon, Deborah A., Zurakowski, David, Mao, Hui, Moses, Marsha A., Auguste, Debra T.·2014·Proceedings of the National Academy of Sciences

Abstract

Significance: Triple negative breast cancers (TNBCs) have a poor prognosis (5-y survival of 74.5%) among all breast cancer patients (5-y survival of greater than 95%) because of the aggressiveness of the disease and the lack of targeted therapeutics. We show that intercellular adhesion molecule-1 (ICAM-1) is differentially expressed in human TNBC tumor tissues by immunohistochemistry and in human TNBC cell lines via quantification of gene and protein expression. Iron oxide nanoparticles functionalized with ICAM-1 antibody (ICAM-IONP) were synthesized as MRI probes. An in vivo signal enhancement of 2.6-fold for ICAM-IONPs was measured relative to controls, demonstrating that ICAM-1 is a potential diagnostic and therapeutic target for TNBC treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.1408556111

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 192

Metadata

Authors
Guo, P., Huang, J., Wang, L., Jia, D., Yang, J., Dillon, D. A., Zurakowski, D., Mao, H., Moses, M. A., & Auguste, D. T.
Venue
Proceedings of the National Academy of Sciences
Published
2014-09-29
Volume
111
Issue
41
Pages
14710-14715
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W1968020290
Cited by
192
References
0
FWCI
4.66
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: ICAM-1 as a molecular target for triple negative breast cancer. https://app.cochat.ai/papers/10.1073/pnas.1408556111
The paper
Guo, P., Huang, J., Wang, L., Jia, D., Yang, J., Dillon, D. A., Zurakowski, D., Mao, H., Moses, M. A., & Auguste, D. T. (2014). ICAM-1 as a molecular target for triple negative breast cancer. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1408556111

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.